Keywords: Shanghai Pharma, China Health System, GlaxoSmithKline, Nanjing MeiRui, M&A

Shanghai Pharma to acquire majority stake in China Health System for up to $600 million: GlaxoSmithKline on China hunt?

Article | 02 December 2010

Print This

Shanghai Pharmaceutical Holding, China's second-largest drug company by revenue, said on Tuesday that it plans to acquire a 55.45% stake in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in